Neuronetics (STIM) Cost of Revenue (2017 - 2026)

Neuronetics (STIM) has reported Cost of Revenue for 10 consecutive years, with $20.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cost of Revenue changed 0.02% year-over-year to $20.3 million in Q2 2026; TTM through Jun 2026 was $78.9 million, a 61.97% increase from a year earlier, with the FY2025 full-year figure at $76.8 million, up 270.73% from the prior year.
• Cost of Revenue was $20.3 million for Q2 2026 at Neuronetics, up from $18.3 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $20.3 million in Q2 2025 and troughed at $3.5 million in Q1 2022.
• A 5-year average of $9.5 million and a median of $4.7 million in 2023 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue declined 26.0% in 2024 and soared 376.47% in 2025, its largest moves.
• Over 5 years, Cost of Revenue stood at $4.4 million in 2022, then rose by 3.49% to $4.5 million in 2023, then jumped by 67.29% to $7.6 million in 2024, then jumped by 164.12% to $20.1 million in 2025, then rose by 1.36% to $20.3 million in 2026.
• The last three Cost of Revenue figures came in at $20.3 million (Q2 2026), $18.3 million (Q1 2026), and $20.1 million (Q4 2025), per Business Quant data.